We will use this function to update you on new developments or activities in therapeutic guidelines for the MUHC - stay tuned!
Please feel free to click on Like (or Dislike!) as needed, and join our discussion!
The ASP team
Correction made for Heart transplant and Lung transplant recipients: both anti-mold AND anti-PJP prophylaxis recommended.
To MUHC users: Please note that as of Dec 5, 2022, requests for outpatient antiviral management of COVID-19 for HIGH RISK patients should be directed to the ID-AMB (formerly MicroB/Lachine) service ra
The MUHC ASP committee is happy to announce the update and publication of several guidelines: Pre-exposure prophylaxis to COVID : Recommended Evusheld dose is now increased to 300/300 mg COVID managem
